Overview

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

Status:
Active, not recruiting

Trial end date:
2021-06-05

Target enrollment:

Participant gender:

Summary

This randomized phase II/III trial studies how well haloperidol with or without chlorpromazine works in treating delirium in patients with cancer that has spread to other parts of the body or has come back. Haloperidol and chlorpromazine may control the symptoms of delirium (loss of contact with reality) in patients with cancer.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

M.D. Anderson Cancer Center

Collaborators:

National Cancer Institute (NCI)
National Institute of Nursing Research (NINR)
National Institutes of Health (NIH)

Treatments:

Chlorpromazine
Haloperidol
Haloperidol decanoate